Condition: Endometrial Cancer · Stage III Endometrial Cancer · Stage III Endometrial Carcinoma · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to find out whether short-course radiation therapy (1 week instead of the usual 5 weeks) with chemotherapy (carboplatin and paclitaxel) is practical (feasible), meaning that most participants are able to complete the treatment schedule.
This description comes directly from the study's public registry record.
Kaled Alektiar, MD · 212-639-7981 · alektiak@mskcc.org
Vicky Makker, MD · 646-888-4224 · makkerv@mskcc.org
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Basking Ridge (All protocol activities) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (All protocol activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (All protocol activities) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Commack (All protocol activities) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (All protocol activities) | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (All protocol activities) | Uniondale, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05691010